AKT1 and ovarian cancer: Furthermore, we have demonstrated that failure to induce mitochondrial release and nuclear accumulation of AIF may be an important determinant of resistance to CDDP in ovarian cancer cells, and that Akt activation may confer resistance, in part, through modulation of this pathway.